“Recordati has a long history of entrepreneurial passion, a strong reputation and a desire to continue growing and creating value in an ethical, enduring, and sustainable way, all while respecting the laws and regulations that apply in the countries where we operate, protecting people and the environment, and supplying safe, high-quality products for our patients. In order to do this, we must work together and respect the fundamental rules and shared values that apply to all of us and all our interactions with others.” 
Andrea Recordati

The Recordati group’s commitment to sustainability

The Recordati group is convinced of the fundamental importance of generating value through an approach that is ethical, lasting, sustainable and shared with stakeholders. Over the years, it has launched various initiatives focused on sustainability, aligned with strategic, organisational and operational characteristics.
In fact, when defining the Group’s management strategies and policies, in addition to ensuring the Group’s development at an international level and focusing on the treatment of rare diseases, one of the Group’s priorities is to identify the interests of all stakeholders, monitoring and managing the economic, social and environmental impacts of its work.

Additional information can be found in the Consolidated Non – Financial Statement and in Sustainability Plan